Image source: The Motley Fool.
Esperion Therapeutics, inc (NASDAQ: ESPR)
Q2 2021 Earnings Call
Aug 3, 2021 , 8:00 a.m. ET
Operator
For further details see:
Esperion Therapeutics, inc (ESPR) Q2 2021 Earnings Call TranscriptImage source: The Motley Fool.
Esperion Therapeutics, inc (NASDAQ: ESPR)
Q2 2021 Earnings Call
Aug 3, 2021 , 8:00 a.m. ET
Operator
For further details see:
Esperion Therapeutics, inc (ESPR) Q2 2021 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
Market:
Esperion Therapeutics Inc. Website:
ANN ARBOR, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that the company will be participating in the followin...
ANN ARBOR, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of May, which can be found on our investor relations website . Jefferies Global Healthcare Confer...
– NILEMDO (bempedoic acid), a First-In-Class, Oral Treatment and NUSTENDI (bempedoic Acid / Ezetimibe Fixed-Dose Combination) Receive Label Update Approval from The European Commission as Treatments to Reduce Cardiovascular Risk by Lowering Low-Density Lipoprotein Cholesterol (LDL-C) Level...